The cell-grown fish from Wildtype, which will be available in a fine-dining restaurant, marks the first time cultivated ...

DermaSensor today announced the publication of two pivotal studies validating its device for skin cancer detection in primary ...

The Lumipulse test has specifically been approved to help diagnose the disease in the clinical setting. Dr. Amanada Smith ...

Exoskeleton developer Wandercraft has raised $75 million in new financing, shortly after inking a strategic partnership with ...

Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ('Thiogenesis' or the 'Company') a clinical-stage biotechnology company developing disulfides that drive the production of intracellular ...

Merck (MRK) stock is in focus as its Enflonsia RSV shot is cleared for infants in the U.S. in a market led by Sanofi (SNY) ...

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $149.5, with a ...

SINTX is actively pursuing strategic partnerships and licensing opportunities to expand the reach of its technology. The company’s near-term focus includes: Joint Ventures: Collaborating with ...

Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions, according to a June 12 news release. THe FDA’s 510(k) clearance was based on safety testing ...